Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$0.8 - $1.05 $76 - $100
-96 Reduced 0.54%
17,702 $15,000
Q4 2023

Feb 13, 2024

SELL
$0.72 - $1.15 $715 - $1,143
-994 Reduced 5.29%
17,798 $16,000
Q3 2023

Nov 15, 2023

SELL
$1.08 - $2.54 $14,867 - $34,965
-13,766 Reduced 42.28%
18,792 $22,000
Q2 2023

Aug 11, 2023

BUY
$2.31 - $3.06 $27,546 - $36,490
11,925 Added 57.8%
32,558 $79,000
Q4 2022

Aug 11, 2023

BUY
$6.39 - $8.8 $13,035 - $17,952
2,040 Added 10.97%
20,633 $145,000
Q4 2022

Feb 13, 2023

BUY
$6.39 - $8.8 $13,035 - $17,952
2,040 Added 10.97%
20,633 $145,000
Q3 2022

Aug 11, 2023

SELL
$7.99 - $10.75 $6,855 - $9,223
-858 Reduced 4.41%
18,593 $160,000
Q3 2022

Nov 03, 2022

SELL
$7.99 - $10.75 $6,855 - $9,223
-858 Reduced 4.41%
18,593 $160,000
Q2 2022

Aug 11, 2023

BUY
$4.58 - $17.13 $22,327 - $83,508
4,875 Added 33.45%
19,451 $160,000
Q2 2022

Aug 15, 2022

BUY
$4.58 - $17.13 $22,327 - $83,508
4,875 Added 33.45%
19,451 $161,000
Q1 2022

Aug 11, 2023

SELL
$12.3 - $18.33 $74,501 - $111,024
-6,057 Reduced 29.36%
14,576 $242,000
Q1 2022

May 20, 2022

SELL
$12.3 - $18.33 $30,528 - $45,495
-2,482 Reduced 14.55%
14,576 $242,000
Q4 2021

Feb 16, 2022

BUY
$7.44 - $16.72 $20,050 - $45,060
2,695 Added 18.76%
17,058 $285,000
Q3 2021

Nov 12, 2021

BUY
$4.85 - $9.73 $69,660 - $139,751
14,363 New
14,363 $124,000
Q2 2021

Aug 12, 2021

SELL
$4.93 - $6.46 $104,215 - $136,557
-21,139 Closed
0 $0
Q1 2021

May 03, 2021

SELL
$5.24 - $6.99 $11,617 - $15,496
-2,217 Reduced 9.49%
21,139 $126,000
Q4 2020

Feb 12, 2021

BUY
$4.77 - $6.58 $25,004 - $34,492
5,242 Added 28.94%
23,356 $122,000
Q3 2020

Nov 09, 2020

BUY
$4.36 - $5.5 $4,168 - $5,258
956 Added 5.57%
18,114 $88,000
Q2 2020

Aug 10, 2020

BUY
$3.6 - $7.75 $13,046 - $28,086
3,624 Added 26.78%
17,158 $94,000
Q1 2020

May 15, 2020

BUY
$2.77 - $5.75 $37,489 - $77,820
13,534 New
13,534 $59,000

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $446M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.